AI Science Tracker
EN

Advancing leprosy risk prediction through identification of a whole blood host transcriptomic biomarker signature including non-coding genes

Leiden University Center of Infectious Diseases (LUCID), Leiden University Medical Center (LUMC), Leiden, The Netherlands; Center for Technological Development in Health, Fiocruz, Rio de Janeiro, Brazil; Leiden Institute of Advanced Computer Science, Leiden Faculty of Science, Leiden, The Netherlands; Research program, The Leprosy Mission International Bangladesh, Nilphamari, Bangladesh · 27 Dec 2025 · medicine

Discovery

Advancing leprosy risk prediction through identification of a whole blood host transcriptomic biomarker signature including non-coding genes

Source check: Source checked. Not independent scientific confirmation.

Finding: The study reports a three-gene signature (SNHG5, SNHG8 and C6orf48) for distinguishing progressors from household contacts, with high reported AUC in discovery and follow-up analyses. RT-qPCR tested selected genes in a separate cohort of 12 progressors and 12 household contacts; 12 of 14 tested genes were confirmed. This is a small single-region validation and not a validated clinical diagnostic.

Technology: Random-forest and support-vector-machine feature selection on blood RNA-seq data identified a candidate host-transcriptomic signature associated with leprosy progression.

Publication: Peer-reviewed paper · Test context: retrospective or benchmark. Catalog categories, not an evidence grade.

AI contribution
Random-forest and support-vector-machine feature selection on blood RNA-seq data identified a candidate host-transcriptomic signature associated with leprosy progression.
Test and result
The study reports a three-gene signature (SNHG5, SNHG8 and C6orf48) for distinguishing progressors from household contacts, with high reported AUC in discovery and follow-up analyses.
Limitation / still unknown
RT-qPCR tested selected genes in a separate cohort of 12 progressors and 12 household contacts; 12 of 14 tested genes were confirmed. This is a small single-region validation and not a validated clinical diagnostic.
Evidence sources and annotation context

Evidence context (descriptions follow the cited sources; test type is a catalog classification):

Evidence sources: https://www.nature.com/articles/s41598-025-33878-8.pdf

Source checked · editorial details

The source page was checked against this entry. Independent confirmation is not assessed by this label.

Source type: paper. Paper: not linked in this catalog; this does not mean no paper exists.

Review date: 22 Nov 2026. Review scope: Primary source full text Methods and Results; version/date checked against bibliographic record..

No follow-up recorded; this is not a claim that no follow-up exists. Follow-up review scope and date are not recorded. No source-supported relationships recorded.

Editorial assessment: Impact 3/5 · Validation 2/5 · Novelty 3/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.

Open in the full catalog for filters, charts and related discoveries. Browse medicine discoveries.